Citeline Connect Key to Record-Setting Clinical Trial Recruitment
Use Case
Patient Engagement & Recruitment

A late-stage biotechnology company developing a next-generation vaccine against COVID-19 was set to conduct a large Phase III trial. The trial design was aligned with other Phase III trials conducted under the auspices of Operation Warp Speed, and planned with specific recruitment diversity goals and an enrollment target of 30,000 volunteers. Location of trial sites emphasized communities and demographic groups most impacted by the disease, including people over age 65 and those living with comorbid conditions that placed them at higher risk of complications from COVID-19.